Anthrax Vaccine Causes Gulf War Syndrome
xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">
http://www.anthraxvaccine.org/AnthraxGWS.htm Anthrax Vaccine Causes Gulf War Syndrome
Until 1998, there existed no
published papers that explored whether receiving anthrax vaccine was
related to Gulf War illnesses. Instead, several expert committees
(lacking experience with anthrax) were asked to comment on whether anthrax
vaccine was likely to be a cause of Gulf War Illnesses. The
committees were given DOD briefings, did not review the literature (there were no
published studies of safety or efficacy for the licensed anthrax vaccine),
concluded that a relationship was unlikely, and then recommended
against further research (1). Studying American veterans was
particularly difficult because many were not told whether they were given
anthrax vaccine, and the vaccinations were specifically not entered
into service members' shot records. Other centralized vaccine records have
been lost. Despite concerns about the investigational status of anthrax
vaccine when used for biological warfare, no informed consent was
obtained from service members at the time of the Gulf War, and no
waiver of informed consent was sought from the FDA. The Canadian Department of
National Defense (DND) hired a consulting company (Goss Gilroy Inc.) to
study the health of Canadian Gulf Veterans and look at various
exposures. Their report was published on the DND website. They found a
significant relationship between receiving non-routine (biological warfare)
immunizations and developing chronic fatigue, a very common symptom of
GWS (2). In 1999 a British study examined
a large number of Gulf War exposures in large cohorts of British Gulf War
and non-deployed Gulf-era veterans, and Bosnia veterans. They
found that for both the Gulf War and the Bosnia veterans, receiving
anthrax vaccine was related to developing an illness consistent with Gulf War
Syndrome (GWS). They wrote, "Vaccination against
biological warfare and multiple routine vaccinations were associated with
the CDC multi-symptom syndrome in the Gulf War cohort (3)." This group published a follow-up
paper in the British Medical Journal that claimed that only Gulf War
veterans who received vaccines after deployment, not before, showed
this relationship. However, they later retracted this conclusion, and
acknowledged that the timing of vaccination did not affect the
relationship between vaccination and GWS. A study of Kansas Gulf War
veterans was published in 2000 (4). This study also found that deployment
vaccines were related to GWS: 34% of Gulf War veterans met the
definition for GWS, while only 4% of
non-deployed, non-vaccinated Gulf-era veterans met the definition. However,
12% of Kansas Gulf-era veterans who were vaccinated in preparation for
deployment, but then were not sent to the Gulf, also met the GWS
definition. The paper concluded, "Vaccines used during the war may be a
contributing factor." A second study of British Gulf
War veterans was published in 4/2001. This study looked at the
relationship between various Gulf War exposures and subsequent health. It
did not look at specific deployment vaccines, but instead evaluated the number
of vaccinations received in relation to GWS. It said, "Consistent,
specific, and credible relations, warranting further investigation, were found
between health indices and two exposures, the reported number of
inoculations and days handling pesticides (5)." The Veterans Administration
collected data on thousands of Gulf War veterans who presented for
evaluation of Gulf War Syndrome. Although unpublished, the data were presented
at a conference on GWS in January 2001 (6). The VA
asked veterans if they thought they had received anthrax vaccine at the time of the Gulf
War, among many other potential exposures, and inquired about
symptoms of illness. Those who believed they had received anthrax vaccine
were twice as likely to report a multitude of symptoms as those
who believed they were not vaccinated. These are all the Gulf War data
that are available in the open literature. Every study
that examined the question of whether vaccines in general, or specific
non-routine vaccines, or anthrax vaccine alone may have contributed to GWS, has
found a positive relationship. The French Ministry of Defense
(MOD) recently convened an advisory committee to study GWS chaired by
Professor Roger Salamon. This committee reviewed the existing
world literature on GWS, and suggested that "multiple vaccinations
given during the war, particularly those for anthrax, botulinum and plague,
seem associated with an excess of (GWS) signs and symptoms (7)." There are no published long-term
adverse event data from the anthrax vaccine immunization program,
which began vaccinating servicemembers in March, 1998. However, the
unpublished study done by Captain Jean Tanner at Dover Air Force Base suggests
that recent anthrax vaccine recipients face similar medical problems as
the Gulf War veterans (8). Meryl Nass, MD 207 865-7000 mnass@anthraxvaccine.org ________________________ 1. Expert committees listed in my
Testimony to the House National Security Subcommittee, April 29,
1999. http://www.house.gov/reform/na/hearings/testimony/nass2.htm 2. http:// www.dnd.ca/menu/press/Reports/Health/health_study_eng_1.htm
3. Unwin C et al. Health of UK
servicemen who served in the Persian Gulf War. The Lancet 1999;
353:169-178. 4. Steele L. Prevalence and
patterns of Gulf War Illness in Kansas veterans: Association of symptoms
with characteristics of person, place, and time of military service. Am
J Epidemiol 2000; 152:991-1001. 5. Cherry N et al. Health and
exposures of United Kingdom Gulf War veterans. Part II: The relation of health to
exposure. Occup Environ Med 2001; 58: 299-306. 6. Mahan CM, Kang HK, Ishii
EK et al. Anthrax vaccination and self-reported symptoms,
functional status and medical conditions in the national health survey of Gulf
War era veterans and their families. Environmental Epidemiology
Service, Veterans Health Administration, Washington, DC. Presented January
25, 2001 @ Research Working Group: Military and Veterans Health
Coordinating Board Conference on Illnesses among Gulf War Veterans: A Decade
of Scientific Research 7. www.gulflink.org/france/RAPPORTa.doc 8. www.anthraxvaccine.org/Report.pdf www.anthraxvaccine.org/data.pdfwww.anthraxvaccine.org/remarkst.pdf ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER. |